Evolent Health Valuation
| EVH Stock | USD 12.21 0.96 8.53% |
At this time, the firm appears to be undervalued. Evolent Health shows a prevailing Real Value of $20.58 per share. The current price of the firm is $12.21. Our model computes the value of Evolent Health from reviewing the firm fundamentals such as Profit Margin of (0.03) %, current valuation of 1.83 B, and Shares Outstanding of 115.03 M as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Evolent Health's valuation include:
Price Book 1.2459 | Enterprise Value 1.8 B | Enterprise Value Ebitda 29.6856 | Price Sales 0.5251 | Forward PE 10.4167 |
Undervalued
Today
Please note that Evolent Health's price fluctuation is somewhat reliable at this time. Calculation of the real value of Evolent Health is based on 3 months time horizon. Increasing Evolent Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Evolent Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Evolent Stock. However, Evolent Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 12.21 | Real 20.58 | Target 46.78 | Hype 11.42 | Naive 10.26 |
The intrinsic value of Evolent Health's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Evolent Health's stock price.
Estimating the potential upside or downside of Evolent Health helps investors to forecast how Evolent stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Evolent Health more accurately as focusing exclusively on Evolent Health's fundamentals will not take into account other important factors: When choosing an evaluation method for Evolent Health, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using all methods to arrive at a better estimate.
Evolent Health Cash |
|
Evolent Valuation Trend
Evolent Health's real value analysis enables investors to forecast the earnings more efficiently. Using both Evolent Health's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing decisions.
Evolent Health Total Value Analysis
Evolent Health is currently anticipated to have company total value of 1.83 B with market capitalization of 1.29 B, debt of 644.8 M, and cash on hands of 188.2 M. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the Evolent Health fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.83 B | 1.29 B | 644.8 M | 188.2 M |
Evolent Health Investor Information
About 96.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.25. Some equities with similar Price to Book (P/B) outperform the market in the long run. Evolent Health recorded a loss per share of 0.92. The entity had not issued any dividends in recent years. Based on the key indicators obtained from Evolent Health's historical financial statements, Evolent Health is not in a good financial situation at this time. It has a very high odds of going through financial crisis in December.Evolent Health Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The recent return on assets of Evolent signifies not a very effective usage of assets in November.Evolent Health Ownership Allocation
The majority of Evolent Health outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to obtain positions in Evolent Health to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Evolent Health. Please pay attention to any change in the institutional holdings of Evolent Health as this could imply that something significant has changed or is about to change at the company. Please note that on May 29, 2020, Representative Greg Gianforte of US Congress acquired $50k to $100k worth of Evolent Health's common stock.Evolent Health Profitability Analysis
The company reported the last year's revenue of 1.96 B. Reported Net Loss for the year was (113.04 M) with profit before taxes, overhead, and interest of 316.58 M.About Evolent Health Valuation
An absolute valuation paradigm, as applied to Evolent Stock, attempts to find the value of Evolent Health based on its fundamental and basic technical indicators. By analyzing Evolent Health's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Evolent Health's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Evolent Health. We calculate exposure to Evolent Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Evolent Health's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 460.5 M | 483.5 M | |
| Pretax Profit Margin | (0.10) | (0.10) | |
| Operating Profit Margin | (0.04) | (0.04) | |
| Net Loss | (0.06) | (0.05) | |
| Gross Profit Margin | 0.23 | 0.19 |
Evolent Health Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 111.3 M | |
| Forward Price Earnings | 10.4167 |
Evolent Health Current Valuation Indicators
Valuation refers to the process of determining the present value of Evolent Health and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Evolent we look at many different elements of the entity such as Evolent's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Evolent Health, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Evolent Health's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Evolent Health's worth.Complementary Tools for Evolent Stock analysis
When running Evolent Health's price analysis, check to measure Evolent Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolent Health is operating at the current time. Most of Evolent Health's value examination focuses on studying past and present price action to predict the probability of Evolent Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolent Health's price. Additionally, you may evaluate how the addition of Evolent Health to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Stocks Directory Find actively traded stocks across global markets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |